Filing Details
- Accession Number:
- 0000784199-24-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-22 17:08:07
- Reporting Period:
- 2024-02-20
- Accepted Time:
- 2024-02-22 17:08:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 784199 | Artivion Inc. | AORT | Surgical & Medical Instruments & Apparatus (3841) | 592417093 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408470 | P James Mackin | Artivion, Inc. 1655 Roberts Blvd, Nw Kennesaw GA 30144 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-20 | 59,225 | $16.30 | 611,105 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-20 | 59,225 | $18.85 | 551,880 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-20 | 10,088 | $18.87 | 541,792 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-20 | 2,756 | $18.87 | 539,036 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option(Right to Buy) | Disposition | 2024-02-20 | 59,225 | $0.00 | 59,225 | $16.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-02-21 | 2024-02-21 | No | 4 | M | Direct |
Footnotes
- The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023.
- Reflects weighted average price. Range of prices were between $18.05 to $19.295. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.
Billionaire Hedge Funds
